• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AMGA Statement on 2022 Medicare Advantage Advance Notice

Article

AMGA recommended that the Centers for Medicare & Medicaid Services (CMS) finalize a number of its proposed policies for the Medicare Advantage program.

Alexandria, VA – AMGA today recommended that the Centers for Medicare & Medicaid Services (CMS) finalize a number of its proposed policies for the Medicare Advantage program. AMGA and its members are strong supporters of the MA program, which offers a financing mechanism and benefit package that helps support care coordination.

AMGA also recommended that CMS continue to recognize the effect of COVID-19 and ensure that audio-only visits remain available for providers and their patients. CMS should allow audio-only telephone calls to satisfy the face-to-face requirement for collecting diagnosis information for risk adjustment purposes.

Read the full press release here.

Related Videos
Pregnant Patient | image credit: pressmaster - stock.adobe.com
Dr Julie Patterson, National Pharmaceutical Council
Diana Isaacs, PharmD
Beau Raymond, MD
Robert Zimmerman, MD
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Kimberly Westrich, MA
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.